An in vivo and in vitro Investigation of the Phototoxic Potential of Tenoxicam, a New Non-Steroidal Anti-Inflammatory Agent
- 1 January 1987
- journal article
- research article
- Published by S. Karger AG in Dermatology
- Vol. 175 (5) , 229-234
- https://doi.org/10.1159/000248909
Abstract
The phototoxic potential of tenoxicam, a new non-steroidal anti-inflammatory drug (NSAID), was investigated following oral and intradermal administration of the drug. No hypersensitivity responses to ultraviolet radiation (UVR) were observed for either orally or intradermally administered tenoxicam. In a parallel in vitro study, human polymorphonuclear leucocytes (PMNL) and mononuclear leucocytes (MNL) were exposed to UVR in the presence and absence of the NSAIDs tenoxicam, piroxicam and benoxaprofen (10–40 μg/ml). The generation of reactive oxidants by control and UVR-treated human PMNL and MNL in the presence and absence of the NSAIDs was measured according to the extent of luminol-enhanced chemiluminescence. Only benoxaprofen activated reactive oxidant generation by PMNL and MNL. The results of these in vitro and in vivo studies show that phototoxicity is unlikely to complicate chemotherapy with tenoxicam.Keywords
This publication has 3 references indexed in Scilit:
- Pharmacological and biochemical activities of Tenoxicam (Ro 12-0068), a new non-steroidal anti-inflammatory drugInflammation Research, 1984
- The Role of Active Oxygen (102 and 0·2-) Induced by Crude Coal Tar and Its Ingredients Used in Photochemotheraphy of Skin DiseasesJournal of Investigative Dermatology, 1984
- A study of benoxaprofen-induced photosensitivityBritish Journal of Dermatology, 1982